Advertise on podcast: Empowered!

In this EPEP podcast, Dr. Gabriela Hobbs, Clinical Director of the Leukemia Service at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School, examines the clinical gray areas of MPN progression, including discordance between symptoms and molecular risk. She also discusses treatment timing and approaches to communicating evolving risk without creating unnecessary anxiety. See more from Empowering Providers to Empower Patients: bit.ly/46m88mh

Dr. Gabriela Hobbs, Clinical Director of the Leukemia Service at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School, speaks to the complexities of caring for patients with myeloproliferative neoplasms (MPNs), particularly when symptoms, laboratory findings, and perceived risk don’t tell the same story. She shares practical insights on navigating these disconnects, strengthening patient-provider communication, and supporting more informed, individualized MPN care. Link to full transcript

Conversations about MPN progression can become increasingly complex as patients face treatment escalation, clinical trial consideration, and long-term planning. In this EPEP podcast, Dr. John Mascarenhas, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, shares his approach to guiding patients through these critical transition points.  He discusses tailoring conversations to the individual patient, presenting treatment and clinical trial options with transparency, and balancing honesty, hope, and uncertainty while supporting informed decision-making. +Link to Full Transcript

In this episode of the Empowering Providers to Empower Patients (EPEP) podcast, host Dr. Nicole Rochester interviews Dr. Leanne Woods-Burnham about the hidden blind spots shaping cancer outcomes today. From misclassified cell lines to overlooked risk factors in primary care, this insightful conversation reveals where provider awareness falls short, and how those gaps translate into missed opportunities for early detection, equitable screening, and truly personalized care. Key Topics in this Podcast Hidden blind spots in provider awareness that limit early detection and screeningHow genetic ancestry, tumor heterogeneity, and protein expression influence precision medicineWhy PSA screening guidance fails to reach high-risk groups, and how to fix itThe importance of individualized screening conversations in primary careCommunity-based initiatives like Blitz the Barriers that improve outcomes for highest-risk populations See More from Empowering Providers to Empower Patients (EPEP)

In Episode 3 of our DECODE podcast, Dr. Virginia Haoyu Sun of Harvard Medical School dives into one of the most critical conversations in modern cancer care: how to use artificial intelligence safely, responsibly, and ethically. She speaks to how bias enters AI systems, what trust in digital health tools really means, and how patients and care partners can thoughtfully engage with AI without replacing human judgment. From protecting privacy to understanding algorithmic limitations, Dr. Sun equips patients and care partners with practical guidance to stay informed and empowered as AI becomes an increasingly influential part of their care journey. See More from DECODE

In this episode of the Empowering Providers to Empower Patients (EPEP) podcast, host Dr. Nicole Rochester speaks with Dr. Demetria Smith-Graziani from Emory University School of Medicine about advancing trust, communication, and equity in breast cancer care. Together, they explore what it means for healthcare systems to truly reflect community voices and lived experience, how to ensure new innovations reach all patients, and why listening is one of the most powerful tools for building trust. Key Topics in this Podcast: Building and sustaining trust across breast cancer diagnosis, treatment, and survivorshipIntegrating lived experience and community voices into equitable care modelsExpanding inclusion in innovation and clinical trials for underrepresented populationsStrengthening communication and shared decision-making between providers and patientsSee More from Empowering Providers to Empower Patients (EPEP)

This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in this Podcast: Understanding the unique landscape of bladder cancer and recent treatment innovationsIdentifying at-risk populations and addressing access barriers, including rural and socioeconomically disadvantaged communitiesBridging the generalist-specialist divide in complex cancer careEmpowering patients through clear communication, treatment education, and shared decision-makingFull transcript here.

This inaugural episode of the Empowering Providers to Empower Patients (EPEP) podcast features Dr. Andrew Laccetti, medical oncologist and Director of Quality for Hematology and Medical Oncology at NYU Langone’s Perlmutter Cancer Center. Dr. Laccetti explores the rapidly evolving landscape of prostate cancer care and shares strategies for overcoming practice inertia, addressing healthcare disparities, and personalizing treatment to meet each patient where they are. Learn actionable approaches to shared decision-making, building patient trust, and empowering patients to participate actively in their care. Key Topics in this Podcast: Addressing healthcare disparities in marginalized communitiesOvercoming practice inertia in prostate cancer careEnhancing shared decision-making with patients and care partnersPersonalizing care to each patient’s needs and preferences

In this DECODE episode, host Lisa Hatfield speaks with Dr. Virginia Sun of Massachusetts General Hospital about how AI, particularly large language models like ChatGPT, is already changing cancer care. From identifying immune-related side effects to easing documentation burdens, they explore what’s hype, what’s real, and what patients should know as they navigate cancer in an increasingly tech-driven world.

In this DECODE podcast, Empowerment Lead Lisa Hatfield and Dr. Virginia Sun explore how artificial intelligence, especially large language models (LLMs), is transforming cancer care. From diagnosing adverse events to streamlining clinician workflows, they unpack what patients need to know, clarify common concerns, and discuss how AI can improve outcomes while preserving the irreplaceable human connection in medicine. Link to full transcript. See more from DECODE: powerfulpatients.org/decode

START HERE bridges the gap between expert and patient voices, empowering myeloma patients to feel comfortable asking precise questions of their healthcare team. In this webinar, Dr. Ola Landgren delves into the emerging and exciting therapies and clinical trials for myeloma, discusses the latest options for relapsed disease, and explores the current landscape of managing and monitoring multiple myeloma. Watch as Dr. Landgren answers patient-submitted questions and discusses another hot topic: the utilization of artificial intelligence in multiple myeloma. Download Guide | Descargar Guía See More from START HERE Myeloma

With the quickly evolving landscape of myeloma treatment and care, it’s important to work with your healthcare team to determine a care plan. In this program, Dr. Omar Nadeem discusses the latest updates in research and clinical trials, the role of new and emerging therapies-- including bispecific antibodies and CAR T-cell therapy--and shares advice for accessing quality myeloma care. Dr. Omar Nadeem is the Clinical Director of the Myeloma Immune Effector Cell Therapy Program and Associate Director of the Multiple Myeloma Clinical Research Program at the Dana-Farber Cancer Institute. Learn more about Dr. Nadeem. Download Resource Guide See More from Evolve Myeloma

Myelofibrosis treatment and care is evolving quickly so it’s essential to understand your options and work with your healthcare team when making treatment decisions. In this webinar, Dr. Gaby Hobbs will discusses the latest updates in research and clinical trials, the role of new and emerging myelofibrosis therapies, and shares advice for accessing quality care. Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the care of patients with myeloproliferative neoplasms (MPN), chronic myeloid leukemia and leukemia. Dr. Hobbs serves as clinical director of the adult leukemia service at Massachusetts General Hospital. Learn more about Dr. Gaby Hobbs. Download Resource Guide See More from Evolve Myelofibrosis

START HERE bridges the expert and patient voice, enabling patients facing a kidney cancer diagnosis to feel comfortable asking precise questions of their healthcare team. In this program, Dr. Moshe Ornstein offers invaluable insights into renal cell carcinoma (RCC), equipping newly diagnosed patients with essential information on treatment priorities, as well as strategies for managing progression and recurrence. Download Resource Guide

In this START HERE myeloma program, Dr. Sikander Ailawadhi from Mayo Clinic spotlights priorities in the rapidly expanding myeloma treatment landscape. Watch as Dr. Ailawadhi addresses pressing questions submitted by patients and families, providing invaluable guidance and reassurance in navigating the complexities of myeloma care. Download Guide  |  Descargar Guía See More from START HERE Myeloma